Image for illustrative purposes only. Not a real photo.

Rhythm Biosciences taps 4Cyte for ColoSTAT distribution

Written by Isaac FrancisPublished Feb 17, 2026, 12:30 AMLast Updated Jul 6, 2026, 10:45 AM

Rhythm Biosciences (ASX:RHY) entered into a strategic distribution service agreement with 4Cyte Pathology, one of Australia's largest independent pathology providers.

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs Explore Australia companies Find the right ASX index

More ways to discover

Assets related to this article